Dark Forest Capital Management LP Corcept Therapeutics Inc Transaction History

Dark Forest Capital Management LP

  • $634 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $181,663 - $284,776
6,156 New
6,156 $284,000
Q3 2023

Nov 13, 2023
BUY
$21.97 - $33.8 $425,866 - $655,179
19,384 New
19,384 $528,000
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $30,403 - $45,659
1,524 New
1,524 $30,000
Q3 2021

Nov 12, 2021
SELL
$19.68 - $22.53 $198,059 - $226,741
-10,064 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$19.97 - $24.43 $200,978 - $245,863
10,064 New
10,064 $221,000

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email